Amyloidosis is a rare protein-related condition that occurs when your body produces too many amyloid proteins, causing damage ...

Megan Alford raises awareness about amyloidosis, a rare disease that can lead to organ failure, after her mother's diagnosis and death from the disease in 2020.

Phase 3 – REVEAL study with 124 I-evuzamitide in patients with suspected cardiac amyloidosis is ongoing by Brigham and Women’s Hospital, Boston, MA. AT-05 (99mTc-p5+14), a radiotracer ...

Amyl’s candidate has the potential to interrupt the formation of amyloid aggregates and disrupt existing plaques that are causing tissue and organ damage. These anti-amyloidosis effects of Amyl ...

124 I-evuzamitide PET/CT demonstrated uptake in multiple organs with amyloid deposition utilizing cutoffs from automated quantification in patients with AL and ATTR amyloidosis. Phase 3 – REVEAL ...